Lactose (India) Ltd.

61.60 -2.58 ▼-4.0%

04 October 2023, 04:01:00 PM
Volume: 6,231

Company Profile

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.lactoseindialimited.com
Market Cap 77.96 Cr.
Enterprise Value(EV) 115.87 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 1.65 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 37.54 Trailing Twelve Months Ending 2023-06
Industry PE 37.76 Trailing Twelve Months Ending 2023-06
Book Value / Share 32.98 Trailing Twelve Months Ending 2023-06
Price to Book Value 1.88 Calculated using Price: 61.93
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.26 Cr. 12,589,000 Shares
FaceValue 10
About Lactose (India) Ltd.
Lactose (India), a Toshniwal Group company, was incorporated in 1991, under the Companies Act, 1956. Its plant in Vadodara, Gujarat was commissioned by Alfa Laval, Pune (which is a subsidary of Alfa Laval of Sweden) and was also given a ‘thumbs up' by reputed dairy experts from the Netherlands in October 1991. Subsequently Alfa Laval, reputed dairy experts from Sweden and a joint commission from the Netherlands studied the plant and its working and confidently acknowledged the plant for its quality standards as well.

Lactose (India) Ltd. Delivery

Delivered Qty
Traded Qty

Lactose (India) Ltd. Performance

1 Day
-4.02%
1 Week
-5.97%
1 Month
-11.26%
3 Month
+26.20%
6 Month
+46.67%
1 Year
-8.81%
2 Year
+49.88%
5 Year
+17.67%
10 Year
+710.53%

Lactose (India) Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 3.25 15.69 11.95 -4.59 2.20 0.21 -7.21 6.65 3.03
Return on Capital Employed (%) 7.55 14.75 14.78 4.08 9.13 7.84 2.81 10.21 9.35
Return on Assets (%) 0.71 3.44 3.30 -1.59 0.88 0.09 -2.88 2.75 1.26

Lactose (India) Ltd. Balance Sheet

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 15 16 20 27 32 34 34 35 39 41
Non Curr. Liab. 30 44 37 31 38 35 38 42 36 35
Curr. Liab. 16 20 26 27 13 12 11 12 15 27
Minority Int.
Equity & Liab. 60 80 83 85 83 82 84 88 90 102
Non Curr. Assets 47 67 66 68 66 64 64 69 67 64
Curr. Assets 13 13 17 17 17 18 20 20 23 38
Misc. Exp. not W/O
Total Assets 60 80 83 85 83 82 84 88 90 102

Lactose (India) Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 24 34 36 31 41 40 35 46 66 84
Other Income 0 1 1 1 0 0 0 1 1 1
Total Income 24 36 37 32 41 40 35 47 67 84
Total Expenditure -19 -24 -24 -25 -31 -31 -29 -34 -54 -71
PBIDT 5 12 12 6 10 10 7 13 12 14
Interest -3 -4 -4 -5 -5 -6 -5 -5 -6 -6
Depreciation -2 -3 -3 -4 -4 -4 -4 -5 -5 -5
Taxation 0 -1 -2 1 0 0 1 -1 0 -1
Exceptional Items
PAT 1 3 3 -1 1 0 -2 2 1 2
Adjusted EPS 1 3 3 -1 1 0 -2 2 1 2

Lactose (India) Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 7 13 1 8 0 5 7 2 8 8
Cash Fr. Inv. -21 -23 3 -5 -2 -2 -3 -6 -1 -1
Cash Fr. Finan. 13 10 -5 -3 4 -5 -4 5 -8 -8
Net Change -1 -1 0 0 3 -2 1 1 0 -1
Cash & Cash Eqvt 1 0 0 0 3 1 2 2 2 1

Lactose (India) Ltd. Shareholding Pattern

9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 49.13 49.13 52.50 53.79 53.79 53.79 53.79 53.79 53.79
Public 50.87 50.87 47.50 46.21 46.21 46.21 46.21 46.21 46.21
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 47.15 47.15 41.21 39.13 0.52 0.52 48.34 48.34 0.00

Lactose (India) Ltd. Announcements

Fri, 29 Sep 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Reg 39(3) of SEBI (LODR) 2015 this is to inform you that the company has received intimation about loss of share certificate.
Fri, 29 Sep 2023
Closure of Trading Window
As per the companys code of Internal Procedures and Conduct for regulating monitoring and reporting of trading by designated person and their immediate relatives of the company read with SEBI(PIT) Reg 2015 the trading window will remain close from 01st October 2023 and shall reopen after expiry of 48 hours after the declaration of financial results for the quarter ended 30th september 2023 generally made available to public.
Wed, 27 Sep 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Reg 39(3) of SEBI (LODR) Reg 2015 this is to inform you that the company has received intimation about loss of share certificate.

Lactose (India) Ltd. Technical Scans

Wed, 04 Oct 2023
Close Crossing Last Week Low Close Crossing Last Week Low
Close Crossing Last Month Low Close Crossing Last Month Low
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Below Last Week Low Close Below Last Week Low
Close Below Last Month Low Close Below Last Month Low

Lactose (India) Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 269,145.40 1,121.75 -1.8%
Divi's Laboratories Ltd. 98,393.27 3,702.05 -0.5%
Cipla Ltd. 94,222.95 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. 90,284.76 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. 72,588.97 5,048.70 -1.4%
Mankind Pharma Ltd. 72,396.35 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. 63,113.31 1,865.70 -0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 31.91 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-06 66.52 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-06 30.29 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.12 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 108.58 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 56.53 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 50.11 1,865.70 -0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.64 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-06 7.49 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-06 3.87 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.68 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.57 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 5.92 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.60 1,865.70 -0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 0.02 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,865.70 -0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,865.70 -0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,865.70 -0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,865.70 -0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,865.70 -0.8%

Lactose (India) Ltd. FAQ's

What is Lactose India share price?

Can I buy Lactose India shares now?

What is the Market Cap of Lactose India?

What are the key metrics to analyse Lactose India?

What is the 52 Week High and Low of Lactose India?

What is the trend of Lactose India share price?